A new trading day began on Monday, with Rocket Pharmaceuticals Inc (NASDAQ: RCKT) stock price up 5.42% from the previous day of trading, before settling in for the closing price of $3.32. RCKT’s price has ranged from $2.19 to $15.00 over the past 52 weeks.
A company in the Healthcare sector has dropped its sales by -11.60% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 24.90%. With a float of $99.59 million, this company’s outstanding shares have now reached $108.21 million.
Rocket Pharmaceuticals Inc (RCKT) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Rocket Pharmaceuticals Inc is 7.98%, while institutional ownership is 86.14%. The most recent insider transaction that took place on Nov 18 ’25, was worth 7,592. In this transaction an insider of this company sold 2,545 shares at a rate of $2.98, taking the stock ownership to the 299,064 shares. Before that another transaction happened on Nov 18 ’25, when Company’s CEO sold 6,276 for $2.98, making the entire transaction worth $18,721. This insider now owns 778,296 shares in total.
Rocket Pharmaceuticals Inc (RCKT) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.62 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 24.90% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 21.89% during the next five years compared to -11.60% drop over the previous five years of trading.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Trading Performance Indicators
Here are Rocket Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.25, a number that is poised to hit -0.43 in the next quarter and is forecasted to reach -1.56 in one year’s time.
Technical Analysis of Rocket Pharmaceuticals Inc (RCKT)
Let’s dig in a bit further. During the last 5-days, its volume was 1.34 million. That was inferior than the volume of 3.31 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 88.39%.
During the past 100 days, Rocket Pharmaceuticals Inc’s (RCKT) raw stochastic average was set at 40.60%, which indicates a significant decrease from 98.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.19 in the past 14 days, which was lower than the 0.21 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.42, while its 200-day Moving Average is $4.52. However, in the short run, Rocket Pharmaceuticals Inc’s stock first resistance to watch stands at $3.57. Second resistance stands at $3.64. The third major resistance level sits at $3.76. If the price goes on to break the first support level at $3.37, it is likely to go to the next support level at $3.25. Assuming the price breaks the second support level, the third support level stands at $3.18.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Key Stats
With a market capitalization of 378.78 million, the company has a total of 108,222K Shares Outstanding. Currently, annual sales are 0 K while annual income is -258,750 K. The company’s previous quarter sales were 0 K while its latest quarter income was -50,330 K.
